Isaly Samuel D

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Isaly Samuel D
CIK #0001055949
EDGAR Form CIK 2011 - 2026
3 [0001055949]
4 [0001055949]
Form 3/4/5 Subject 2011 - 2026
Isaly Samuel D
OrbiMed Advisors LLC
Xtant Medical Holdings Inc
OrbiMed Capital GP VI LLC
Kala Bio Inc
Palvella Therapeutics Inc
OrbiMed Capital GP III LLC
OrbiMed Capital GP V LLC
Loxo Oncology Inc
scPharmaceuticals Inc
X4 Pharmaceuticals Inc
OrbiMed Capital GP IV LLC
Rhythm Pharmaceuticals Inc
Sorrento Tech Inc
Audentes Therapeutics Inc
GLAUKOS Corp
Synlogic Inc
Alpine Immune Sciences Inc
CTI Biopharma Corp
OrbiMed Israel GP II LP
SteadyMed Ltd
OrbiMed Advisors Israel II Ltd
Adaptimmune Therapeutics PLC
Whitehawk Therapeutics Inc
Spyre Therapeutics Inc
ViewRay Inc
Nabriva Therapeutics PLC
OrbiMed Asia GP LP
Response Biomedical Corp
OrbiMed Advisors Ltd
Relypsa Inc
Cartesian Therapeutics Inc
Corvus Pharmaceuticals Inc
OrbiMed Global Healthcare GP LLC
Intellia Therapeutics Inc
Otonomy Inc
Dimension Therapeutics Inc
Project Sage Oldco Inc
OrbiMed Private Investments V LP
Sierra Oncology Inc
Intercept Pharmaceuticals Inc
Mirati Therapeutics Inc
Acceleron Pharma Inc
OrbiMed Capital GP II LLC
Ambit Biosciences Corp
Supernus Pharmaceuticals Inc
Anthera Pharmaceuticals Inc
Amarin Corp PLC UK
Complete Genomics Inc
Pacira BioSciences Inc
ChemoCentryx Inc
OrbiMed Capital LLC
OrbiMed Capital GP I LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kala Bio Inc KALA
Common Stock
2018-01-12 Buy 28,446 $15.40 438,068
Kala Bio Inc KALA
Common Stock
2018-01-11 Buy 41,700 $13.65 569,205
Kala Bio Inc KALA
Common Stock
2018-01-10 Buy 170,338 $12.83 2,185,437
Palvella Therapeutics Inc PIRS
Common Stock
2018-01-03 Sell 1,693,492 $7.35 12,447,166
Palvella Therapeutics Inc PIRS
Common Stock
2018-01-03 Sell 16,128 $7.35 118,541
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 47 $5.64 265
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
2017-12-18 Option exercise 50 $0.00
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 10,180 $1.62 16,492
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 97 $1.62 157
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
2017-12-18 Option exercise 5,227 $0.00
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 4,971 $5.64 28,036
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
2017-12-18 Option exercise 83 $0.00
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
2017-12-18 Option exercise 14,858 $0.00
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
2017-12-18 Option exercise 10,447 $0.00
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 83 $1.94 161
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 189 $1.59 301
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 142 $2.01 285
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
2017-12-18 Option exercise 99 $0.00
Palvella Therapeutics Inc PIRS
Common Stock
2017-12-18 Option exercise 97 $2.01 195
Palvella Therapeutics Inc PIRS
Stock Option (right to buy) · derivative
2017-12-18 Option exercise 8,097 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com